Transcriptomic predictors of rapid progression from mild cognitive impairment to Alzheimer's disease
Abstract Background Effective treatment for Alzheimer’s disease (AD) remains an unmet need. Thus, identifying patients with mild cognitive impairment (MCI) who are at high-risk of progressing to AD is crucial for early intervention. Methods Blood-based transcriptomics analyses were performed using a...
Saved in:
Main Authors: | Yi-Long Huang, Tsung-Hsien Tsai, Zhao-Qing Shen, Yun-Hsuan Chan, Chih-Wei Tu, Chien-Yi Tung, Pei-Ning Wang, Ting-Fen Tsai |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2025-01-01
|
Series: | Alzheimer’s Research & Therapy |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13195-024-01651-0 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Quality of Life in Mild Cognitive Impairment and Mild Dementia Associated with Alzheimer’s Disease: A Systematic Review
by: Joanna Campbell, et al.
Published: (2024-11-01) -
Functional and effective EEG connectivity patterns in Alzheimer’s disease and mild cognitive impairment: a systematic review
by: Elizabeth R. Paitel, et al.
Published: (2025-02-01) -
Incidence and Prevalence of Alzheimer’s Disease in Medicare Beneficiaries
by: Haixin Zhang, et al.
Published: (2024-12-01) -
Alzheimer’s disease may develop from changes in the immune system, cell cycle, and protein processing following alterations in ribosome function
by: Akiko Yamakawa, et al.
Published: (2025-01-01) -
Blood-based biomarkers in mild behavioral impairment: an updated overview
by: Efthalia Angelopoulou, et al.
Published: (2025-02-01)